The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125404906 12540490 6 F 20151026 20160829 20160708 20160902 EXP CA-SA-2015SA172507 AVENTIS 30.00 YR A F Y 95.50000 KG 20160902 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125404906 12540490 1 PS LEMTRADA ALEMTUZUMAB 1 Intravenous drip F3005H23 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
125404906 12540490 2 SS DIPHENHYDRAMINE. DIPHENHYDRAMINE 1 Intravenous (not otherwise specified) 4F667 0 25 MG
125404906 12540490 3 SS DIMENHYDRINATE. DIMENHYDRINATE 1 Intravenous (not otherwise specified) 3H034 0 25 MG
125404906 12540490 4 SS METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 7190315 0 1 G
125404906 12540490 5 C CARBAMAZEPINE. CARBAMAZEPINE 1 Oral 0 200 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125404906 12540490 1 Relapsing-remitting multiple sclerosis
125404906 12540490 2 Rash
125404906 12540490 3 Nausea
125404906 12540490 4 Throat irritation
125404906 12540490 5 Sleep disorder

Outcome of event

Event ID CASEID OUTC COD
125404906 12540490 LT
125404906 12540490 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125404906 12540490 Arthralgia
125404906 12540490 Basedow's disease
125404906 12540490 Bladder disorder
125404906 12540490 Blood thyroid stimulating hormone decreased
125404906 12540490 Condition aggravated
125404906 12540490 Creatinine urine decreased
125404906 12540490 Creatinine urine increased
125404906 12540490 Dizziness
125404906 12540490 Dysphonia
125404906 12540490 Dyspnoea
125404906 12540490 Fatigue
125404906 12540490 Goitre
125404906 12540490 Haemoglobin increased
125404906 12540490 Haemoglobin urine present
125404906 12540490 Headache
125404906 12540490 Heart rate increased
125404906 12540490 Hyperhidrosis
125404906 12540490 Leukocyturia
125404906 12540490 Lymphocyte count decreased
125404906 12540490 Mean cell volume decreased
125404906 12540490 Muscular weakness
125404906 12540490 Myalgia
125404906 12540490 Palpitations
125404906 12540490 Papillary thyroid cancer
125404906 12540490 Red blood cell count increased
125404906 12540490 Red blood cells urine
125404906 12540490 Throat irritation
125404906 12540490 Thyroxine free increased
125404906 12540490 Tremor
125404906 12540490 Urine abnormality
125404906 12540490 Weight increased
125404906 12540490 White blood cells urine positive

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125404906 12540490 1 20151026 20151028 0
125404906 12540490 2 20151026 20151026 0
125404906 12540490 3 20151026 20151026 0
125404906 12540490 4 20151026 20151026 0
125404906 12540490 5 20151208 0